These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38728860)

  • 1. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
    Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
    J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer application of ferrocene appended configuration-regulated half-sandwich iridium(III) pyridine complexes.
    Wang Z; Lv Z; Liu X; Wu Y; Chang J; Dong R; Li C; Yuan XA; Liu Z
    J Inorg Biochem; 2022 Dec; 237():112010. PubMed ID: 36152469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents.
    Liu X; Wang Z; Zhang X; Lv X; Sun Y; Dong R; Li G; Ren X; Ji Z; Yuan XA; Liu Z
    J Inorg Biochem; 2023 Dec; 249():112393. PubMed ID: 37806004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
    Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
    Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial targeting half-sandwich iridium(III) and ruthenium(II) dppf complexes and in vitro anticancer assay.
    Liu J; Wu Y; Yang G; Liu Z; Liu X
    J Inorg Biochem; 2023 Feb; 239():112069. PubMed ID: 36423395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
    Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
    Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance.
    Guo L; Li P; Jing Z; Gong Y; Lai K; Fu H; Dong H; Yang Z; Liu Z
    J Inorg Biochem; 2024 Sep; 258():112631. PubMed ID: 38843774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and anticancer behaviour of cationic/neutral half-sandwich iridium(III) imidazole-phenanthroline/phenanthrene complexes.
    Lv A; Li G; Zhang P; Tao R; Li X; Ren X; Li P; Liu X; Yuan XA; Liu Z
    J Inorg Biochem; 2024 Aug; 257():112612. PubMed ID: 38761579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
    Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z
    Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
    Kacsir I; Sipos A; Bényei A; Janka E; Buglyó P; Somsák L; Bai P; Bokor É
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
    Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z
    Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
    Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
    Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
    Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
    Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.